The University of Chicago Header Logo

Connection

Jon E. Grant to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Jon E. Grant has written about Treatment Outcome.
Jon E. Grant
Connection Strength
1.845
Treatment Outcome
  1. Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial. Clin Neuropharmacol. 2024 Mar-Apr 01; 47(2):54-58.
    View in: PubMed
    Score: 0.099
  2. Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder?: A Case Series Using Phenelzine. J Clin Psychopharmacol. 2021 Jul-Aug 01; 41(4):461-464.
    View in: PubMed
    Score: 0.082
  3. A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder. Int J Eat Disord. 2019 07; 52(7):786-794.
    View in: PubMed
    Score: 0.071
  4. Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions. Neuropsychol Rev. 2019 03; 29(1):93-102.
    View in: PubMed
    Score: 0.070
  5. Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2):129-134.
    View in: PubMed
    Score: 0.070
  6. Placebo response in trichotillomania. Int Clin Psychopharmacol. 2017 11; 32(6):350-355.
    View in: PubMed
    Score: 0.064
  7. Double-blind switch study of vilazodone in the treatment of major depressive disorder. Int Clin Psychopharmacol. 2017 05; 32(3):121-126.
    View in: PubMed
    Score: 0.062
  8. Refractory OCD Due to Thalamic Infarct With Response to Dronabinol. J Neuropsychiatry Clin Neurosci. 2017; 29(1):77-78.
    View in: PubMed
    Score: 0.059
  9. Silymarin treatment of obsessive-compulsive spectrum disorders. J Clin Psychopharmacol. 2015 Jun; 35(3):340-2.
    View in: PubMed
    Score: 0.054
  10. A single-blind study of 'as-needed' ecopipam for gambling disorder. Ann Clin Psychiatry. 2014 Aug; 26(3):179-86.
    View in: PubMed
    Score: 0.051
  11. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb; 34(1):134-8.
    View in: PubMed
    Score: 0.049
  12. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014 Jan; 75(1):39-45.
    View in: PubMed
    Score: 0.049
  13. A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Eur Neuropsychopharmacol. 2013 Nov; 23(11):1587-96.
    View in: PubMed
    Score: 0.048
  14. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013 Jun; 27(2):380-92.
    View in: PubMed
    Score: 0.047
  15. The relationship of tobacco use with gambling problem severity and gambling treatment outcome. Psychol Addict Behav. 2013 Sep; 27(3):696-704.
    View in: PubMed
    Score: 0.045
  16. Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry. 2012 May; 24(2):119-26.
    View in: PubMed
    Score: 0.044
  17. Neurocognitive response to deep brain stimulation for obsessive-compulsive disorder: a case report. Am J Psychiatry. 2011 Dec; 168(12):1338-9.
    View in: PubMed
    Score: 0.042
  18. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl). 2011 Dec; 218(3):493-502.
    View in: PubMed
    Score: 0.041
  19. A 6-month follow-up of imaginal desensitization plus motivational interviewing in the treatment of pathological gambling. Ann Clin Psychiatry. 2011 Feb; 23(1):3-10.
    View in: PubMed
    Score: 0.040
  20. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
    View in: PubMed
    Score: 0.039
  21. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010 Dec; 212(4):603-12.
    View in: PubMed
    Score: 0.039
  22. A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010 Aug; 30(4):396-403.
    View in: PubMed
    Score: 0.039
  23. Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial. Br J Psychiatry. 2009 Sep; 195(3):266-7.
    View in: PubMed
    Score: 0.036
  24. Pathologic gambling and bankruptcy. Compr Psychiatry. 2010 Mar-Apr; 51(2):115-20.
    View in: PubMed
    Score: 0.036
  25. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
    View in: PubMed
    Score: 0.033
  26. Lamotrigine treatment of pathologic skin picking: an open-label study. J Clin Psychiatry. 2007 Sep; 68(9):1384-91.
    View in: PubMed
    Score: 0.032
  27. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007 Sep 15; 62(6):652-7.
    View in: PubMed
    Score: 0.031
  28. N-acetyl cysteine in the treatment of grooming disorders. J Clin Psychopharmacol. 2007 Apr; 27(2):227-9.
    View in: PubMed
    Score: 0.031
  29. Late-onset obsessive compulsive disorder: clinical characteristics and psychiatric comorbidity. Psychiatry Res. 2007 Jul 30; 152(1):21-7.
    View in: PubMed
    Score: 0.031
  30. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):80-5.
    View in: PubMed
    Score: 0.031
  31. Medication management of pathological gambling. Minn Med. 2006 Sep; 89(9):44-8.
    View in: PubMed
    Score: 0.029
  32. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
    View in: PubMed
    Score: 0.028
  33. Outcome study of kleptomania patients treated with naltrexone: a chart review. Clin Neuropharmacol. 2005 Jan-Feb; 28(1):11-4.
    View in: PubMed
    Score: 0.026
  34. Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation. J Geriatr Psychiatry Neurol. 2004 Mar; 17(1):9-12.
    View in: PubMed
    Score: 0.025
  35. Effectiveness of pharmacotherapy for pathological gambling: a chart review. Ann Clin Psychiatry. 2002 Sep; 14(3):155-61.
    View in: PubMed
    Score: 0.022
  36. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
    View in: PubMed
    Score: 0.022
  37. Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry. 2002 Apr; 11(2):92-5.
    View in: PubMed
    Score: 0.022
  38. A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry. 2001 Dec; 13(4):229-31.
    View in: PubMed
    Score: 0.021
  39. Interstitial laser anterior capsulotomy for obsessive-compulsive disorder: lesion size and tractography correlate with outcome. J Neurol Neurosurg Psychiatry. 2022 03; 93(3):317-323.
    View in: PubMed
    Score: 0.021
  40. Treatment of agitation and aggression in four demented patients using ECT. J ECT. 2001 Sep; 17(3):205-9.
    View in: PubMed
    Score: 0.021
  41. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001 Sep; 16(5):285-9.
    View in: PubMed
    Score: 0.021
  42. The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 2001 Jul; 6(3):184-94.
    View in: PubMed
    Score: 0.021
  43. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry. 2001 Apr; 62(4):297-8.
    View in: PubMed
    Score: 0.020
  44. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
    View in: PubMed
    Score: 0.013
  45. The effectiveness of a cognitive-behavioral intervention for pathological gambling: a country-wide study. Ann Clin Psychiatry. 2013 Nov; 25(4):250-6.
    View in: PubMed
    Score: 0.012
  46. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013 Mar; 52(3):231-40.
    View in: PubMed
    Score: 0.012
  47. Effects of acute modafinil on cognition in trichotillomania. Psychopharmacology (Berl). 2010 Dec; 212(4):597-601.
    View in: PubMed
    Score: 0.010
  48. Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010 Feb; 22(1):56-62.
    View in: PubMed
    Score: 0.009
  49. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res. 2009 May 15; 167(1-2):161-8.
    View in: PubMed
    Score: 0.009
  50. Decreased memory loss associated with right unilateral ultra-brief pulse wave ECT. Minn Med. 2007 Jan; 90(1):34-5.
    View in: PubMed
    Score: 0.008
  51. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002 Jun; 63(6):501-7.
    View in: PubMed
    Score: 0.005
  52. Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc. 2000 Jul; 75(7):673-80.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.